BioStorage Technologies Showcases First-Ever Mobile Biorepository – Relofleet at Drug Information Association Annual Meeting

INDIANAPOLIS, June 13, 2011 /PRNewswire/ — At this year’s Drug Information
Association Annual Meeting (DIA), BioStorage Technologies will showcase
Relofleet(TM) – the first mobile biorepository designed specifically for sample
relocation within North America. This novel sample transport technology allows
for the customized transportation of entire sample inventories and associated
equipment, while assuring the shipment reaches its destination on time and in
optimal condition.

The custom-made, 53-foot trailer accommodates all temperatures from frozen to
room temperature and is capable of simultaneously transporting a multitude of
biomaterials, clinical trial samples, API and manufactured drugs. Equipped with
redundant generator systems, the unit also allows BioStorage Technologies to
transport freezers and refrigerators with or without samples.

Relofleet contains a built-in, mobile workstation that conforms to FDA 21 CFR
Part 11 compliance standards and provides audit tracking of samples from
site-to-site within the BioStorage Technologies ISSIS (Intelligent Specimen
Inventory Storage System) database. Sample asset security is provided in-transit
via 360 degree internal and external tracking and monitoring provided by 12
security cameras.

“Designed to respond to a growing need for compliant and cost-effective
solutions for shipping temperature-sensitive biological samples and materials,
Relofleet is the first of its kind,” said Russ Hager, Global Director of Supply
Chain, BioStorage Technologies.

“With its multiple uses and innovative technology, Relofleetallows our
specialized team of logistics experts to provide door-to-door, full-scale
support during the entire sample lifecycle management process.”

As with all of BioStorage Technologies’ processes and systems, Relofleetis
validated to adhere to U.S. Food and Drug Administration regulations and the
U.S. Department of Transportation guidelines.

Showcased for the first time at the DIA conference, Relofleet will be available
for tours Monday June 20th from 6:30 – 8:00 p.m. at McCormick Place. In
addition, Lori Ball, Chief Operating Officer at BioStorage Technologies, will be
presenting a scientific poster titled “Best Practices for Designing and
Implementing Effective Data Capture of Clinical Trial Samples and Associated
Data.” The poster will highlight validated data from a recent pilot study
conducted by BioStorage Technologies and a leading drug developer. BioStorage
Technologies will be exhibiting at booth #1443 as well.

For more information on BioStorage Technologies, please visit
www.biostorage.com.

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is the premier, global provider of comprehensive
sample management solutions for the bioscience industry. Offering both onsite
and outsourced sample management services to companies around the world,
BioStorage Technologies delivers high quality and compliant life-cycle
management of scientific samples assets. With a team of global sample experts,
state-of-the-art temperature-controlled storage facilities and a real-time,
web-based sample intelligence and tracking system, the company supports
customers in maximizing opportunities, minimizing risk and reducing the cost of
sample management. BioStorage Technologies, Inc. is privately held and
headquartered in Indianapolis with an additional full-service site near
Frankfurt, Germany. For more information, visit www.biostorage.com or call +1
(866) 697-2675 or +49-6155-898-1011.

Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com

SOURCE BioStorage Technologies, Inc.